The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

A CRO look­ing to build its man­u­fac­tur­ing side busi­ness has a new par­ent af­ter Keen­sight snaps up ma­jor­i­ty stake

5 years ago
Deals
Outsourcing

Chi­nese on­col­o­gy play­er is the lat­est to join the North Car­oli­na man­u­fac­tur­ing par­ty with 2 new plants in the off­ing

5 years ago

Re­silience has caught the eye of the Cana­di­an gov­ern­ment, which will in­vest $163M to boost mR­NA pro­duc­tion

5 years ago
Coronavirus

Af­ter record-break­ing de­mand for in­jecta­bles, BD to ex­pand in Spain with $200M Zaragoza plant

5 years ago
Coronavirus

No­var­tis' San­doz reshuf­fles an­tibi­ot­ic sup­ply chain in EU as field faces a short­age of in­vest­ment

5 years ago

Covid-19 man­u­fac­tur­ing re­port: Ire­land will pro­duce mR­NA com­po­nent for Pfiz­er's vac­cine; Lon­za re­cruits fed­er­al em­ploy­ees for rapid ramp-up

5 years ago
Coronavirus

Ther­mo Fish­er part­ners with UCSF to pro­vide a one-stop shop for ear­ly biotech man­u­fac­tur­ing

5 years ago

Charles Riv­er keeps adding on to its CD­MO arm, snatch­ing up a vi­ral vec­tor play­er for a tidy $350M

5 years ago
Deals

Vac­cine mak­er North­west Bio claims it's in the home­stretch for its man­u­fac­tur­ing ex­pan­sion in the UK

5 years ago

PerkinElmer hits the check­book again, this time dol­ing out $260M for next-gen ther­a­py bioser­vices firm

5 years ago
Deals

Mod­er­na taps in­to Aus­tralia with Covid-19 boost­er deal and the po­ten­tial for lo­cal man­u­fac­tur­ing

5 years ago
Coronavirus

Re­call re­port: No­vo Nordisk re­calls sam­ples of mul­ti­ple in­sulin prod­ucts af­ter stor­age screw-up

5 years ago
FDA+

In the lat­est chap­ter of Emer­gent saga, CEO Bob Kramer will ad­dress US House sub­com­mit­tee on plant woes

5 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Emer­gent starts clean-up ef­fort af­ter dis­as­trous Form 483; Eli Lil­ly ex­pands li­cens­es for In­di­an part­ners

5 years ago
Coronavirus

A clos­er look at the FDA’s more than 700 pan­dem­ic-re­lat­ed record re­quests to re­place on­site in­spec­tions

5 years ago
FDA+

BioN­Tech ex­pands mR­NA man­u­fac­tur­ing to Sin­ga­pore as clam­or for Covid-19 vac­cine and boost­ers swells

5 years ago

Q&A: Ain­drea Camp­bell goes small, step­ping away from Ap­ple to head man­u­fac­tur­ing at Zymer­gen — where am­bi­tions are big

5 years ago
People
Outsourcing

Gold­man Sachs jumps aboard Bain-backed 503(b) com­pound­ing phar­ma­cy with a $275M debt loan to sup­ply hos­pi­tals

5 years ago
Financing
Outsourcing

Lon­za keeps adding on as it looks to beef up bi­o­log­ics of­fer­ing, tack­ing on near­ly $1B in ex­pan­sions in EU, US

5 years ago
Outsourcing

An­oth­er Mod­er­na ex­pan­sion is an­nounced, this time at its Mass­a­chu­setts site

5 years ago

Catal­ent snaps up Promether­a's cell ther­a­py sub­sidiary, com­plete with a Bel­gian plant to help scale plas­mid DNA ef­forts

5 years ago
Outsourcing

Mod­er­na CEO brush­es off US sup­port for IP waiv­er, eyes more than $19B in Covid-19 vac­cine sales in 2021

5 years ago
Coronavirus

Re­call re­port: Acel­la pulls thy­roid tablets af­ter a raft of side ef­fect re­ports; mis­la­bel­ing caus­es Pfiz­er's Hos­pi­ra to yank 2 lots of anes­thet­ics

5 years ago
FDA+

Biden ad­min­is­tra­tion backs a po­lar­iz­ing pro­pos­al to waive IP for all Covid-19 vac­cines

5 years ago
Pharma
FDA+
First page Previous page 71727374757677 Next page Last page
A service from the Financial Times